MDNA55
MDNA55-05
Phase 2 small_molecule completed
Quick answer
MDNA55 for Glioblastoma is a Phase 2 program (small_molecule) at Medicenna Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Medicenna Therapeutics
- Indication
- Glioblastoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed